Bio-Path Holdings Reports Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Bio-Path Holdings (BPTH) Misses Q2 EPS by 9c
August 15, 2023 7:01 AM EDTBio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.
... More